{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T23:52:25Z","timestamp":1780617145848,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"DOI":"10.1186\/s12936-025-05439-x","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T09:17:25Z","timestamp":1749806245000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comprehensive analysis of molecular markers linked to antimalarial drug resistance in Plasmodium falciparum in Northern, Northeastern and Eastern Uganda"],"prefix":"10.1186","volume":"24","author":[{"given":"Peter","family":"Olupot-Olupot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Paasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Katairo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy Patrick","family":"Alunyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Nakiyemba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert Gilibrays","family":"Ocen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Pande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florance","family":"Alaroker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Okiror","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmaluel","family":"Ocen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Oula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles Benard","family":"Okalebo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ongodia","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Amorut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Tukwasibwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan Nabadda","family":"Ndidde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Sewanyana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel L.","family":"Nsobya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,13]]},"reference":[{"key":"5439_CR1","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s40471-021-00266-5","volume":"8","author":"MM Ippolito","year":"2021","unstructured":"Ippolito MM, Moser KA, Kabuya JB, Cunningham C, Juliano JJ. Antimalarial drug resistance and implications for the WHO global technical strategy. Curr Epidemiol Rep. 2021;8:46\u201362.","journal-title":"Curr Epidemiol Rep"},{"key":"5439_CR2","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1111\/febs.14127","volume":"284","author":"AM Thu","year":"2017","unstructured":"Thu AM, Phyo AP, Landier J, Parker DM, Nosten FH. Combating multidrug-resistant Plasmodium falciparum malaria. FEBS J. 2017;284:2569\u201378.","journal-title":"FEBS J"},{"key":"5439_CR3","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12916-015-0384-6","volume":"13","author":"M Tanner","year":"2015","unstructured":"Tanner M, Greenwood B, Whitty CJM, Ansah EK, Price RN, Dondorp AM, et al. Malaria eradication and elimination: views on how to translate a vision into reality. BMC Med. 2015;13:167.","journal-title":"BMC Med"},{"key":"5439_CR4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12936-024-04929-8","volume":"23","author":"J Katushabe","year":"2024","unstructured":"Katushabe J, Nnyanzi JB, Muwanga GS. Exploring the role of spending on malaria incidence in Uganda using the auto-regressive distributed lag approach. Malar J. 2024;23:129.","journal-title":"Malar J"},{"key":"5439_CR5","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJMoa2101746","volume":"385","author":"B Balikagala","year":"2021","unstructured":"Balikagala B, Fukuda N, Ikeda M, Katuro OT, Tachibana S-I, Yamauchi M, et al. Evidence of artemisinin-resistant malaria in Africa. N Engl J Med. 2021;385:1163\u201371.","journal-title":"N Engl J Med"},{"key":"5439_CR6","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1056\/NEJMoa2211803","volume":"389","author":"MD Conrad","year":"2023","unstructured":"Conrad MD, Asua V, Garg S, Giesbrecht D, Niar\u00e9 K, Smith S, et al. Evolution of partial resistance to artemisinins in malaria parasites in Uganda. N Engl J Med. 2023;389:722\u201332.","journal-title":"N Engl J Med"},{"key":"5439_CR7","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1186\/s12936-024-05158-9","volume":"23","author":"BB Agaba","year":"2024","unstructured":"Agaba BB, Travis J, Smith D, Rugera SP, Zalwango MG, Opigo J, et al. Emerging threat of artemisinin partial resistance markers (pfk13 mutations) in Plasmodium falciparum parasite populations in multiple geographical locations in high transmission regions of Uganda. Malar J. 2024;23:330.","journal-title":"Malar J"},{"key":"5439_CR8","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1186\/s12936-023-04817-7","volume":"22","author":"A Singh","year":"2023","unstructured":"Singh A, Singh MP, Ali NA, Poriya R, Rajvanshi H, Nisar S, et al. Assessment of Plasmodium falciparum drug resistance associated molecular markers in Mandla, Madhya Pradesh. India Malar J. 2023;22:375.","journal-title":"India Malar J"},{"key":"5439_CR9","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.3390\/microorganisms10102021","volume":"10","author":"HG L\u00ea","year":"2022","unstructured":"L\u00ea HG, Naw H, Kang JM, V\u00f5 TC, Myint MK, Htun ZT, et al. Molecular profiles of multiple antimalarial drug resistance markers in Plasmodium falciparum and Plasmodium vivax in the Mandalay region, Myanmar. Microorganisms. 2022;10:2021.","journal-title":"Microorganisms"},{"key":"5439_CR10","doi-asserted-by":"publisher","first-page":"6353","DOI":"10.1038\/s41467-022-33873-x","volume":"13","author":"PK Tumwebaze","year":"2022","unstructured":"Tumwebaze PK, Conrad MD, Okitwi M, Orena S, Byaruhanga O, Katairo T, et al. Decreased susceptibility of Plasmodium falciparum to both dihydroartemisinin and lumefantrine in northern Uganda. Nat Commun. 2022;13:6353.","journal-title":"Nat Commun"},{"key":"5439_CR11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12936-017-1777-0","volume":"16","author":"S Tukwasibwe","year":"2017","unstructured":"Tukwasibwe S, Tumwebaze P, Conrad M, Arinaitwe E, Kamya MR, Dorsey G, et al. Drug resistance mediating Plasmodium falciparum polymorphisms and clinical presentations of parasitaemic children in Uganda. Malar J. 2017;16:125.","journal-title":"Malar J"},{"key":"5439_CR12","first-page":"631","volume":"215","author":"P Tumwebaze","year":"2017","unstructured":"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, et al. Changing antimalarial drug resistance patterns identified by surveillance at three sites in Uganda. J Infect Dis. 2017;215:631\u20135.","journal-title":"J Infect Dis"},{"key":"5439_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.868723","volume":"13","author":"M Silva","year":"2022","unstructured":"Silva M, Malmberg M, Otienoburu SD, Bj\u00f6rkman A, Ngasala B, M\u00e5rtensson A, et al. Plasmodium falciparum drug resistance genes pfmdr1 and pfcrt in vivo co-expression during artemether-lumefantrine therapy. Front Pharmacol. 2022;13: 868723.","journal-title":"Front Pharmacol"},{"key":"5439_CR14","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1093\/infdis\/jiaa687","volume":"223","author":"V Asua","year":"2021","unstructured":"Asua V, Conrad MD, Aydemir O, Duvalsaint M, Legac J, Duarte E, et al. Changing prevalence of potential mediators of aminoquinoline, antifolate, and artemisinin resistance across Uganda. J Infect Dis. 2021;223:985\u201394.","journal-title":"J Infect Dis"},{"key":"5439_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12936-021-04023-3","volume":"21","author":"G Manirakiza","year":"2022","unstructured":"Manirakiza G, Kassaza K, Taremwa IM, Bazira J, Byarugaba F. Molecular identification and anti-malarial drug resistance profile of Plasmodium falciparum from patients attending Kisoro Hospital, southwestern Uganda. Malar J. 2022;21:21.","journal-title":"Malar J"},{"key":"5439_CR16","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12936-023-04589-0","volume":"22","author":"C da Silva","year":"2023","unstructured":"da Silva C, Matias D, Dias B, Cancio B, Silva M, Viegas R, et al. anti-malarial resistance in Mozambique: absence of Plasmodium falciparum kelch 13 (K13) propeller domain polymorphisms associated with resistance to artemisinins. Malar J. 2023;22:160.","journal-title":"Malar J"},{"key":"5439_CR17","first-page":"1525","volume":"103","author":"MK Angwe","year":"2024","unstructured":"Angwe MK, Mwebaza N, Nsobya SL, Vudriko P, Dralabu S, Omali D, et al. Day 3 parasitemia and Plasmodium falciparum Kelch 13 mutations among uncomplicated malaria patients treated with artemether-lumefantrine in Adjumani district, Uganda. medRxiv. 2024;103:1525.","journal-title":"medRxiv."},{"key":"5439_CR18","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1093\/infdis\/jiae288","volume":"230","author":"S Tukwasibwe","year":"2024","unstructured":"Tukwasibwe S, Garg S, Katairo T, Asua V, Kagurusi BA, Mboowa G, et al. varied prevalence of antimalarial drug resistance markers in different populations of newly arrived refugees in Uganda. J Infect Dis. 2024;230:497\u2013504.","journal-title":"J Infect Dis"},{"key":"5439_CR19","doi-asserted-by":"publisher","first-page":"565","DOI":"10.4269\/ajtmh.1995.52.565","volume":"52","author":"CV Plowe","year":"1995","unstructured":"Plowe CV, Djimde A, Bouare M, Doumbo O, Wellems TE. Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. Am J Trop Med Hyg. 1995;52:565\u20138.","journal-title":"Am J Trop Med Hyg"},{"key":"5439_CR20","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1093\/infdis\/jiy223","volume":"218","author":"O Aydemir","year":"2018","unstructured":"Aydemir O, Janko M, Hathaway NJ, Verity R, Mwandagalirwa MK, Tshefu AK, et al. Drug-resistance and population structure of Plasmodium falciparum aross the Democratic Republic of Congo using high-throughput molecular inversion probes. J Infect Dis. 2018;218:946\u201355.","journal-title":"J Infect Dis"},{"key":"5439_CR21","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12936-022-04224-4","volume":"21","author":"FM Kagoro","year":"2022","unstructured":"Kagoro FM, Allen E, Mabuza A, Workman L, Magagula R, Kok G, et al. Making data map-worthy-enhancing routine malaria data to support surveillance and mapping of Plasmodium falciparum anti-malarial resistance in a pre-elimination sub-Saharan African setting: a molecular and spatiotemporal epidemiology study. Malar J. 2022;21:207.","journal-title":"Malar J"},{"key":"5439_CR22","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s12936-019-2960-2","volume":"18","author":"C Louren\u00e7o","year":"2019","unstructured":"Louren\u00e7o C, Tatem AJ, Atkinson PM, Cohen JM, Pindolia D, Bhavnani D, et al. Strengthening surveillance systems for malaria elimination: a global landscaping of system performance, 2015\u20132017. Malar J. 2019;18:315.","journal-title":"Malar J"},{"key":"5439_CR23","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12936-022-04115-8","volume":"1","author":"CV Plowe","year":"2022","unstructured":"Plowe CV. Malaria chemoprevention and drug resistance: a review of the literature and policy implications. Malar J. 2022;1:104.","journal-title":"Malar J"},{"key":"5439_CR24","doi-asserted-by":"publisher","first-page":"B17","DOI":"10.1016\/j.ajog.2023.10.031","volume":"230","author":"RG Sinkey","year":"2024","unstructured":"Sinkey RG, Ogunsile FJ, Kanter J, Bean C, Greenberg M. Society for maternal-fetal medicine consult series #68: sickle cell disease in pregnancy. Am J Obstet Gynecol. 2024;230:B17\u201340.","journal-title":"Am J Obstet Gynecol"},{"key":"5439_CR25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00277-010-1040-z","volume":"90","author":"S Diop","year":"2011","unstructured":"Diop S, Soudr\u00e9 F, Seck M, Gu\u00e8ye YB, Di\u00e9ye TN, Fall AO, Sall A, Thiam D, Diakhat\u00e9 L. Sickle-cell disease and malaria: evaluation of seasonal intermittent preventive treatment with sulfadoxine-pyrimethamine in Senegalese patients-a randomized placebo-controlled trial. Ann Hematol. 2011;90:23\u20137.","journal-title":"Ann Hematol"},{"key":"5439_CR26","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/1475-2875-8-237","volume":"8","author":"V Nakibuuka","year":"2009","unstructured":"Nakibuuka V, Ndeezi G, Nakiboneka D, Ndugwa CM, Tumwine JK. Presumptive treatment with sulphadoxine-pyrimethamine versus weekly chloroquine for malaria prophylaxis in children with sickle cell anaemia in Uganda: a randomized controlled trial. Malar J. 2009;8:237.","journal-title":"Malar J"},{"key":"5439_CR27","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1126\/science.314.5801.904b","volume":"314","author":"G Vogel","year":"2006","unstructured":"Vogel G. Chloroquine makes a comeback. Science. 2006;314:904.","journal-title":"Science"},{"key":"5439_CR28","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1186\/1475-2875-12-453","volume":"12","author":"S Mharakurwa","year":"2013","unstructured":"Mharakurwa S, Sialumano M, Liu K, Scott A, Thuma P. Selection for chloroquine-sensitive Plasmodium falciparum by wild Anopheles arabiensis in Southern Zambia. Malar J. 2013;12:453.","journal-title":"Malar J"},{"key":"5439_CR29","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12936-019-2716-z","volume":"18","author":"M Ocan","year":"2019","unstructured":"Ocan M, Akena D, Nsobya S, Kamya MR, Senono R, Kinengyere AA, et al. Persistence of chloroquine resistance alleles in malaria endemic countries: a systematic review of burden and risk factors. Malar J. 2019;18:76.","journal-title":"Malar J"},{"key":"5439_CR30","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1111\/mmi.12349","volume":"89","author":"PJ Rosenthal","year":"2013","unstructured":"Rosenthal PJ. The interplay between drug resistance and fitness in malaria parasites. Mol Microbiol. 2013;89:1025\u201338.","journal-title":"Mol Microbiol"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05439-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-025-05439-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05439-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T09:17:26Z","timestamp":1749806246000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-025-05439-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,13]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5439"],"URL":"https:\/\/doi.org\/10.1186\/s12936-025-05439-x","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,13]]},"assertion":[{"value":"14 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A detailed protocol was developed beforehand and approved by the Mbale Regional Referral Hospital Research Ethics Committee [(MRRH-REC), MRRHREC-OUT-011\/2020] and Uganda National Council for Science and Technology [(UNCST), HS3725ES]. Ethical considerations were adhered to during the study process. The study conformed to the provisions of ethical standards in Uganda.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The Mbale Clinical Research Institute (MCRI, ), a research entity affiliated with the Uganda National Health Research Organization, approved the publication of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"190"}}